BROADWOOD CAPITAL INC - Q2 2022 holdings

$1.33 Billion is the total value of BROADWOOD CAPITAL INC's 8 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 14.3% .

 Value Shares↓ Weighting
STAA  STAAR SURGICAL CO$609,431,000
-11.2%
8,592,0070.0%45.94%
-7.2%
MNST  MONSTER BEVERAGE CORP NEW$431,656,000
+16.0%
4,656,4880.0%32.54%
+21.3%
IWM  ISHARES TRrussell 2000 etf$116,858,000
-17.5%
690,0000.0%8.81%
-13.7%
AXON  AXON ENTERPRISE INC$70,815,000
-32.4%
760,0620.0%5.34%
-29.3%
LCTX  LINEAGE CELL THERAPEUTICS IN$55,198,000
+2.6%
34,935,4850.0%4.16%
+7.3%
OCX BuyONCOCYTE CORP$21,011,000
-18.7%
23,353,697
+34.6%
1.58%
-15.0%
BTRS NewBTRS HOLDINGS INC$19,809,0003,977,701
+100.0%
1.49%
AGE  AGEX THERAPEUTICS INC$1,727,000
-32.5%
2,997,1560.0%0.13%
-29.7%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-08-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
STAAR SURGICAL CO42Q3 202359.1%
MONSTER BEVERAGE CORP NEW34Q3 202349.7%
ISHARES TR33Q3 202314.8%
ONCOCYTE CORPORATION31Q2 20234.6%
BIOTIME INC25Q2 201917.8%
AXON ENTERPRISE INC24Q3 202313.4%
AGEX THERAPEUTICS INC20Q3 20231.5%
LINEAGE CELL THERAPEUTICS INC17Q3 20235.1%
ASTERIAS BIOTHERAPEUTICS INC16Q4 20182.9%
CYNOSURE INC15Q4 201610.4%

View BROADWOOD CAPITAL INC's complete holdings history.

Latest filings
TypeFiled
42024-04-15
13F-HR2024-02-14
42024-02-08
42024-01-10
42024-01-05
42023-11-30
13F-HR2023-11-14
42023-11-14
42023-11-09
42023-11-06

View BROADWOOD CAPITAL INC's complete filings history.

Compare quarters

Export BROADWOOD CAPITAL INC's holdings